| Style | Citing Format |
|---|---|
| MLA | Sanjari Moghaddam H, Akhondzadeh S. "Response to [Palmitoylethanolamide: One Molecule, Different Formulations]." Psychiatry and Clinical Neurosciences, vol. 77, no. 2, 2023, pp. 128-. |
| APA | Sanjari Moghaddam H, Akhondzadeh S (2023). Response to [Palmitoylethanolamide: One Molecule, Different Formulations]. Psychiatry and Clinical Neurosciences, 77(2), 128-. |
| Chicago | Sanjari Moghaddam H, Akhondzadeh S. "Response to [Palmitoylethanolamide: One Molecule, Different Formulations]." Psychiatry and Clinical Neurosciences 77, no. 2 (2023): 128-. |
| Harvard | Sanjari Moghaddam H, Akhondzadeh S (2023) 'Response to [Palmitoylethanolamide: One Molecule, Different Formulations]', Psychiatry and Clinical Neurosciences, 77(2), pp. 128-. |
| Vancouver | Sanjari Moghaddam H, Akhondzadeh S. Response to [Palmitoylethanolamide: One Molecule, Different Formulations]. Psychiatry and Clinical Neurosciences. 2023;77(2):128-. |
| BibTex | @article{ author = {Sanjari Moghaddam H and Akhondzadeh S}, title = {Response to [Palmitoylethanolamide: One Molecule, Different Formulations]}, journal = {Psychiatry and Clinical Neurosciences}, volume = {77}, number = {2}, pages = {128-}, year = {2023} } |
| RIS | TY - JOUR AU - Sanjari Moghaddam H AU - Akhondzadeh S TI - Response to [Palmitoylethanolamide: One Molecule, Different Formulations] JO - Psychiatry and Clinical Neurosciences VL - 77 IS - 2 SP - 128 EP - PY - 2023 ER - |